OpGen Inc (OPGN):企業の財務・戦略的SWOT分析

◆英語タイトル:OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH188486FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

OpGen Inc (OPGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

OpGen Inc (OpGen) is a precision medicine company that harnesses molecular diagnostics and informatics to prevent infectious diseases caused by multi drug resistant organisms (MDROs). OpGen’s develops products that include QuickFISH, and PNA FISH products, Acuitas molecular diagnostic, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc Key Recent Developments

Dec 09,2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01,2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11,2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15,2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05,2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
OpGen Inc – Key Facts
OpGen Inc – Key Employees
OpGen Inc – Key Employee Biographies
OpGen Inc – Major Products and Services
OpGen Inc – History
OpGen Inc – Company Statement
OpGen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
OpGen Inc – Business Description
Product Category: Collaboration Revenue
Overview
Performance
Product Category: Laboratory Services
Overview
Performance
Product Category: Product Sales
Overview
Performance
R&D Overview
OpGen Inc – SWOT Analysis
SWOT Analysis – Overview
OpGen Inc – Strengths
OpGen Inc – Weaknesses
OpGen Inc – Opportunities
OpGen Inc – Threats
OpGen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 09, 2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11, 2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15, 2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05, 2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud
Sep 30, 2020: OpGen announces award of German Government grant funding to its subsidiary Curetis and collaborators
Sep 16, 2020: Collaborative research by OpGen Group company ares genetics and Johns Hopkins researchers demonstrates potential of next-generation sequencing for investigation of genetic antimicrobial resistance mechanisms and molecular susceptibility testing
Aug 12, 2020: OpGen reports second quarter 2020 financial results and provides business update
Jul 15, 2020: OpGen provides business update and announces preliminary unaudited revenue and cash position for second quarter 2020
Jul 13, 2020: Menarini Silicon Biosystems partners with OpGen to broaden distribution of CELLSEARCH platform in North America
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
OpGen Inc, Key Facts
OpGen Inc, Key Employees
OpGen Inc, Key Employee Biographies
OpGen Inc, Major Products and Services
OpGen Inc, History
OpGen Inc, Subsidiaries
OpGen Inc, Key Competitors
OpGen Inc, Ratios based on current share price
OpGen Inc, Annual Ratios
OpGen Inc, Annual Ratios (Cont...1)
OpGen Inc, Interim Ratios
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OpGen Inc (OPGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CryoPort Inc (CYRX):企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • SunOpta Inc.:企業のM&A・事業提携・投資動向
    SunOpta Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SunOpta Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Gazprom Neft (SIBN):石油・ガス:M&Aディール及び事業提携情報
    Summary Gazprom Neft, a subsidiary of Gazprom, is an integrated oil and gas company. It explores for, develops, and produces crude oil and natural gas. The company operates in Khanty-Mansi and Yamalo-Nenets Autonomous Districts, and Tomsk, Omsk and Orenburg regions in Russia; and also has production …
  • Croatia Airlines d.d.:企業の戦略・SWOT・財務情報
    Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Tom N Toms Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tom N Toms Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Bank of Ireland:戦略・SWOT・企業財務分析
    Bank of Ireland - Strategy, SWOT and Corporate Finance Report Summary Bank of Ireland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Jo-Ann Stores, Inc.:企業の戦略・SWOT・財務情報
    Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jo-Ann Stores, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Thales Deutschland GmbH:企業の戦略・SWOT・財務分析
    Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report Summary Thales Deutschland GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Citizens Energy Group:企業の戦略的SWOT分析
    Citizens Energy Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • National Oilwell Varco Inc (NOV)-石油・ガス分野:企業M&A・提携分析
    Summary National Oilwell Varco, Inc. (NOV) designs, manufactures and services a broad range of drilling and well servicing equipment and components for the oil and gas sector. Its offerings include rig systems, wellbore technologies, and completion and production technologies. Its product line compr …
  • Metro AG:企業の戦略・SWOT・財務情報
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Kindred Healthcare Inc (KND):製薬・医療:M&Aディール及び事業提携情報
    Summary Kindred Healthcare Inc (Kindred Healthcare) is a healthcare services provider with focus on post-acute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operate …
  • Merus Labs International Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • Mylan Laboratories Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mylan Laboratories Ltd (Mylan), a subsidiary of Mylan NV is a pharmaceutical company that manufactures and supplies API products. The company offers HIV care products for the treatment of HIV/AIDS. It provides women’s care products for therapies such as hormone replacement therapy, infertili …
  • Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …
  • ArQule Inc (ARQL)-製薬・医療分野:企業M&A・提携分析
    Summary ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including …
  • Bank of the Ryukyus Ltd:企業の戦略・SWOT・財務分析
    Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of the Ryukyus Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ducommun Incorporated:企業の戦略・SWOT・財務情報
    Ducommun Incorporated - Strategy, SWOT and Corporate Finance Report Summary Ducommun Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Marriott International Inc:戦略・SWOT・企業財務分析
    Marriott International Inc - Strategy, SWOT and Corporate Finance Report Summary Marriott International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆